Post-Market Wrap

Thursday, May 21, 2026 · 1:30 PM PT

Market Snapshot

Dow+0.6% · New closing record S&P 500~7,452 (+0.2%) Nasdaq+0.1% 10Y Treasury4.57% (off 4.69% Tue high) WTI Crude$97.40 (-0.9%) Gold$4,540/oz

Dow printed its first closing record in 3+ months. Oil sold off on renewed U.S.-Iran deal optimism. Bond yields eased after touching 4.69% on Tuesday. Risk-on tone across the board.

Watchlist Scoreboard

TickerCloseChangeNote
AAPL $304.99 +0.91% New ATH $305.54 intraday
ASML $1,592 +2.70% UBS top pick, PT EUR1,900
CRWV $107.58 +6.22% $3.1B loan facility, bounce off $100
NVDA $219.51 -1.77% Post-earnings sell-the-news
TSM $407.15 +1.38%
AMZN $268.46 +1.30%
META $607.38 +0.38%
MSFT $419.09 -0.47%
TSLA $417.85 +0.14% SpaceX S-1 filed
AVGO $414.57 -0.76%
GOOGL $387.66 -0.32%

Rotation Entry Zone

NVDA at $219 -- Post-Earnings Dip Is the Setup You Called

NVDA closed at $219.51, down 1.77% despite crushing Q1 ($81.6B revenue, +85% YoY, $91B Q2 guide). Classic sell-the-news. Intraday range $217.93-$227.40.

Analyst PT upgrades post-earnings:

Consensus PT now ~$283, implying 29% upside from today's close. Margins held steady (a key concern heading in). Vera Rubin on track H2 2026. China remains the overhang -- no H20 resolution.

What to consider: Your plan has NVDA at 30% ($90K). At $219, you're buying 29% below consensus PT and 32% below HSBC's $325 target. The sell-the-news dip is exactly the entry pattern you designed the rotation around. If you're ready to start executing, this is the zone. A limit order in the $215-220 range captures the post-earnings digestion window. Markets are closed Monday (Memorial Day) -- any Friday order could have a long weekend of news to absorb.
Thesis Catalyst

ASML +2.7% -- UBS Reinstates as Top European Semi Pick

UBS analyst Francois-Xavier Bouvignies raised PT to EUR1,900 (from EUR1,600) and called ASML the "most attractive risk/reward in the sector." Key thesis points:

Stock hit $1,601.79 intraday, extending its ATH run. Current consensus PT is $1,504 -- ASML is now trading 6% above consensus, but UBS's EUR1,900 (~$2,100+) implies 30%+ upside.

What to consider: Your plan has ASML at 20% ($60K). The stock is extended above consensus but UBS just materially reset the institutional narrative. The 6% P/E premium vs. 84% historical average is a striking valuation gap. If you're uncomfortable entering at ATH, a pullback toward $1,550 would be a cleaner entry. But momentum is clearly bullish.
Stay-Away Watch

CRWV +6.2% -- Dead Cat Bounce or Floor Forming?

CoreWeave bounced 6.2% to $107.58 off the $100 psychological floor (intraday low $103.16). Catalysts: $3.1B loan facility closed, ranked #1 for inference speed in Moonshot AI's Kimi K2.6 benchmarks.

Still, insider selling (CTO Venturo, Magnetar, ARK) was heavy through May 7-8. DA Davidson downgraded to Underperform. The stock is 42% below its 52-week high of $187.

What to consider: "Stay away" remains the right call. The $3.1B facility addresses near-term liquidity but doesn't change the profitability story (net loss $740M in Q1). Wait for insider selling to exhaust and a real floor pattern -- two-three weeks of consolidation above $100 would be the minimum signal. No action needed.
ATH Watch

AAPL $304.99 -- Third Consecutive ATH Session

Apple printed $305.54 intraday, extending the breakout above $300 that began May 20. The rally is on momentum from Q2 FY2026 beat, $100B buyback, and demand for MacBook Neo / AI-powered devices despite TSMC 3nm supply constraints.

Not part of your semi rotation plan, but worth noting: AAPL is now the most expensive Mag 7 name on a P/E basis. If you're trimming META to fund the rotation, AAPL's strength provides a favorable risk backdrop for the broader market.


NVDA Analyst Scorecard

FirmNew PTPrior PTRating
HSBC$325$295Buy
GF Securities$308$292Buy
DA Davidson$300$250Buy
KeyBanc$300$275Overweight
Morgan Stanley$285$260Overweight
TD Cowen$275$235Buy
Aletheia$270$250Buy

Street consensus ~$283. At $219.51, NVDA trades at a 23% discount to the average PT and 32% below the high-water mark.

Tomorrow's Catalysts

Bottom Line for the Rotation

The META -> semi chain rotation plan is staring at its designed entry window. NVDA is in a textbook post-earnings dip with every major analyst raising targets. ASML just got a major institutional upgrade that reinforces the thesis. TSM is holding firm. The macro backdrop (easing yields, oil retreating, Dow at record) is supportive.

The one wrinkle: Memorial Day weekend means any Friday orders sit for three days. If you want to start sizing in, consider placing limit orders Friday morning with the awareness that news flow (Iran deal, OpenAI filing) could move things over the weekend. Alternatively, wait for Tuesday's open for a cleaner read.